Steven Stein

Steven Stein is a Venture Advisor at Israel Biotech Fund. Steven H. Stein, MD, Chief Medical Officer at Incyte Corporation. Dr. Stein’s primary responsibility is leading all the medical and scientific activities involving clinical development, clinical operations, pharmacovigilance, clinical pharmacology, scientific communications, and medical affairs at Incyte.

Dr. Stein previously worked at Novartis Oncology as the Senior Vice President and Head of U.S. Clinical Development and Medical Affairs and prior to that at GlaxoSmithKline as Vice President, Global Oncology, Clinical Development and also as Head of Medicines Development for Hematology and Supportive Care.

Dr. Stein earned his MBBCH from the University of Witwatersrand in Johannesburg, South Africa. He has authored more than 100 scientific papers and presentations and is an Adjunct Assistant Professor in the School of Medicine, University of Pennsylvania.

Dr. Stein is also an active member of several professional and scientific societies and academic committees.